VGLL1 stabilization of cytoplasmic TAZ promotes EGFR expression and maintains tumor initiating cells in breast cancer independent of TEAD
Article in Cellular Signalling (February 2024)
The most recent citing publications are shown below. View all 125 publications that cite this research output on Dimensions.
Homologous recombination deficiency and tumor suppressor heterozygosity mediate resistance to front-line therapy in breast cancer
Preprint in bioRxiv (February 2024)
Data‐adaptive and pathway‐based tests for association studies between somatic mutations and germline variations in human cancers
Article in Genetic Epidemiology (October 2023)